abstract |
FIELD: medicine. n SUBSTANCE: there are described chimeric peptides able to inhibit or attenuate a viral infection. The peptides contain a primary structure which contains at least one segment which delays activation of NS3 protease of virus family Flaviviridae, and a segment penetrating into a cell. What is also disclosed is a pharmaceutical composition containing such chimeric peptides. n EFFECT: invention may be used in medicine. n 5 cl, 6 dwg, 3 tbl, 4 ex |